LEMD1 and colorectal carcinoma: Kaplan–Meier survival analysis suggested that CRC patients with high expression of LEMD1 had worse overall survival (Figure S3C), shorter disease-free survival (Figure 5C) and a higher risk of postoperative recurrence (Figure 5D).